Stock Updates

Is this Large Market Cap Stock target price reasonable for GW Pharmaceuticals plc (NASDAQ:GWPH)?

The company in question is, GW Pharmaceuticals plc (NASDAQ:GWPH) currently with a stock price of 128.15 (-0.30% today). The market cap for GW Pharmaceuticals plc is 3313.5, and is in the sector Healthcare, and Drug Manufacturers РMajor industry. The target price for GW Pharmaceuticals plc is 141.13. Currently GW Pharmaceuticals plc is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for GW Pharmaceuticals plc is 621.35 and so far today it is 130388.

Performance in the last year for GW Pharmaceuticals plc has been 48.97%. For EPS growth, GW Pharmaceuticals plc has seen a growth of -159.60%, and is looking to grow in the next year to -28.80%. More long term stats show that EPS growth has been -48.70% over the last five years and could be *TBA for the next five years. GW Pharmaceuticals plc has seen sales growth quarter over quarter at -73.30%, with EPS growth quarter over quarter at 45.60%. The 20-day simple moving average is 24.53%, with the 200-day simple moving average coming to 58.50%.

Since the IPO date for GW Pharmaceuticals plc on the 05/01/2013, GW Pharmaceuticals plc has seen performance year to date to be 85.10%. With GW Pharmaceuticals plc trading at 128.15, the dividend yield is *TBA, and the EPS is -3.41.

So could GW Pharmaceuticals plc, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 184.08 and the P/B is at 10.86. The P/cash is 13.74, with P/free cash flow at *TBA.

GW Pharmaceuticals plc ability to deal with debt shows that the current ratio is 6.1, and the quick ratio is 6. This is with long term debt/equity at 0.02, and total debt/equity at 0.02.

In terms of margins, GW Pharmaceuticals plc has a gross margin of 81.60%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for GW Pharmaceuticals plc is *TBA. Return on assets come to -21.50% with return on investment coming to -18.10%.

Insider ownership for GW Pharmaceuticals plc, is at *TBA and institutional ownership comes to 61.60%. Outstanding shares are at 25.78. While shares float is 22.22. The float short is currently 11.50%, and short ratio is 4.11.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment